Gene · 7172
Papers3,004
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 3,004
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Relationship Between Thiopurine S-Methyltransferase Genotype and Phenotype in Pediatric Acute Lymphoblastic Leukemia in Addis Ababa, Ethiopia. | J Pediatr Pharmacol Ther | 2025 | 40717760 | PubTator, text mining | PubMed |
| Preventing adverse drug reactions and more: current clinical use of pharmacogenetic testing. | Med Genet | 2025 | 40687883 | PubTator, text mining | PubMed |
| Azathioprine Metabolites in Erythrocytes and DNA for Therapy Monitoring in Very Early Onset Inflammatory Bowel Disease Pediatric Patients. | ACS Pharmacol Transl Sci | 2025 | 40672687 | PubTator, text mining | PubMed |
| DNA-incorporated thioguanine to detect potential non-adherence to maintenance therapy in acute lymphoblastic leukemia. | Cancer Chemother Pharmacol | 2025 | 40668416 | PubTator, text mining | PubMed |
| The NUDIX hydrolase NUDT5 influences purine nucleotide metabolism and thiopurine pharmacology. | J Clin Invest | 2025 | 40662363 | PubTator, text mining | PubMed |
| Predicting protein stability changes upon mutations with dual-view ensemble learning from single sequence. | Brief Bioinform | 2025 | 40641045 | PubTator, text mining | PubMed |
| Clinical impact of pharmacogenetic risk variants in a large chinese cohort. | Nat Commun | 2025 | 40634300 | PubTator, text mining | PubMed |
| Gene polymorphisms associated with immunosuppressant adverse effects in systemic lupus erythematosus: a narrative review. | Front Genet | 2025 | 40630120 | PubTator, text mining | PubMed |
| Population Pharmacokinetics Model of Thioguanine in Patients with Inflammatory Bowel Disease. | Clin Pharmacokinet | 2025 | 40581725 | PubTator, text mining | PubMed |
| Exploring the Pharmacogenetic Landscape: Identification of Clinically Relevant Genotypes by a Nation-Wide Medical Testing Laboratory in Romania. | Pharmaceuticals (Basel) | 2025 | 40573293 | PubTator, text mining | PubMed |
| Using pharmacogenomics to personalise drug therapy: which drugs, when and how. | Aust Prescr | 2025 | 40568692 | PubTator, text mining | PubMed |
| Clinical Pharmacogenetics: Results After Implementation of Preemptive Tests in Daily Routine. | J Pers Med | 2025 | 40559107 | PubTator, text mining | PubMed |
| Bone Marrow Aplasia and Neutropenic Fever Following Azathioprine Dose Escalation in a TPMT-Deficient Patient with Crohn's Disease and Psoriatic Arthritis-A CARE-Compliant Case. | Clin Pract | 2025 | 40558232 | PubTator, text mining | PubMed |
| Transforming IBD care: the future of personalized therapy through multi-omics and pharmacogenomics. | Expert Opin Drug Metab Toxicol | 2025 | 40556317 | PubTator, text mining | PubMed |
| Pharmacogenetic Implementation Studies-Lessons Learned From the PREPARE Study. | Clin Pharmacol Ther | 2025 | 40552566 | PubTator, text mining | PubMed |
Clinical Utility and Cost-Effectiveness of Pretreatment NUDT15 Pharmacogenetic Testing to Prevent Thiopurine-Induced Myelosuppression: A Genotype-First Reverse Phenotyping Cohort Study Within the UK NIHR Inflammatory Bowel Disease Bioresource. | Aliment Pharmacol Ther | 2025 | 40548539 | PubTator, text mining | PubMed |
| PTPN2 and Leukopenia in Individuals With Normal TPMT and NUDT15 Metabolizer Status Taking Azathioprine. | Clin Transl Sci | 2025 | 40442974 | PubTator, text mining | PubMed |
| Assessment of thiopurine S-methyltransferase allele frequencies and phenotype-genotype concordance in a Tunisian population. | Drug Metab Pers Ther | 2025 | 40441128 | PubTator, text mining | PubMed |
| Human Placenta Hydrolysate Protects Against Acetaminophen-Induced Liver Injury in Mice. | Biomedicines | 2025 | 40427046 | PubTator, text mining | PubMed |
| [Intervention effect analysis of TPMT and NUDT15 genotyping on the tolerability of azathioprine or 6-mercaptopurine therapy in pediatric inflammatory bowel disease]. | Zhonghua Er Ke Za Zhi | 2025 | 40393756 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7172/papers?page=6